Zoetis Inc. Files 8-K on Officer Changes and Compensation
Ticker: ZTS · Form: 8-K · Filed: Oct 28, 2025 · CIK: 1555280
| Field | Detail |
|---|---|
| Company | Zoetis Inc. (ZTS) |
| Form Type | 8-K |
| Filed Date | Oct 28, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, compensation
Related Tickers: ZTS
TL;DR
Zoetis filed an 8-K detailing leadership changes and executive pay. Stay tuned for details.
AI Summary
Zoetis Inc. filed an 8-K on October 28, 2025, reporting events as of October 23, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. It also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
This filing provides crucial updates on the company's leadership and executive compensation, which can impact investor confidence and strategic direction.
Risk Assessment
Risk Level: low — This is a routine corporate filing detailing standard board and officer changes, not indicating immediate financial distress or significant operational shifts.
Key Players & Entities
- Zoetis Inc. (company) — Registrant
- October 23, 2025 (date) — Date of earliest event reported
- October 28, 2025 (date) — Filing date
FAQ
What specific officer positions were affected by the changes reported in this 8-K?
The filing indicates "Departure of Directors or Certain Officers" and "Appointment of Certain Officers," but the specific positions are not detailed in the provided text.
Are there any details regarding new compensatory arrangements for officers mentioned in the filing?
The filing lists "Compensatory Arrangements of Certain Officers" as an item, but the specifics of these arrangements are not included in the provided text.
What is the primary reason for this 8-K filing?
The primary reasons are to report the departure/election/appointment of directors and officers, and to disclose compensatory arrangements, along with Regulation FD disclosures and financial statements/exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on October 23, 2025.
What is Zoetis Inc.'s principal executive office address?
Zoetis Inc.'s principal executive offices are located at 10 Sylvan Way, Parsippany, New Jersey 07054.
Filing Stats: 766 words · 3 min read · ~3 pages · Grade level 10.7 · Accepted 2025-10-28 08:33:44
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share ZTS New York Stock Exchange
Filing Documents
- zts-20251023.htm (8-K) — 30KB
- exhibit9912025newdirectort.htm (EX-99.1) — 14KB
- image_0a.jpg (GRAPHIC) — 39KB
- 0001555280-25-000266.txt ( ) — 219KB
- zts-20251023.xsd (EX-101.SCH) — 2KB
- zts-20251023_lab.xml (EX-101.LAB) — 22KB
- zts-20251023_pre.xml (EX-101.PRE) — 13KB
- zts-20251023_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On October 28, 2025, the Company issued a press release announcing the appointment of Ms. Tilenius. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 7.01. The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, unless expressly incorporated by specific reference in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued on October 28, 2025 regarding the appointment of Stephanie Tilenius to the Zoetis Board 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ZOETIS INC. Dated: October 28, 2025 By: /s/ Roxanne Lagano Roxanne Lagano Executive Vice President, General Counsel and Corporate Secretary